rs104894264
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus.
|
14992727 |
2004 |
rs104894264
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors.
|
15604628 |
2004 |
rs104894264
|
|
T |
0.800 |
CausalMutation |
CLINVAR |
Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway.
|
15254225 |
2004 |
rs104894264
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory.
|
15714081 |
2005 |
rs104894264
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Novel mutations in the MEN1 gene in subjects with multiple endocrine neoplasia-1.
|
15730416 |
2005 |
rs104894264
|
|
T |
0.800 |
CausalMutation |
CLINVAR |
Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation.
|
17766710 |
2007 |
rs104894264
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
|
20065170 |
2010 |
rs104894264
|
|
T |
0.800 |
CausalMutation |
CLINVAR |
Correlation of mutant menin stability with clinical expression of multiple endocrine neoplasia type 1 and its incomplete forms.
|
21819486 |
2011 |
rs104894264
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).
|
22723327 |
2012 |
rs104894264
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
|
23788249 |
2013 |
rs104894264
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
|
25394175 |
2015 |
rs104894264
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing.
|
25356965 |
2015 |
rs104894264
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
|
27854360 |
2017 |